Nascent Biotech, Inc. (NBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Jun 17, 2026
Nascent Biotech Market Cap
Nascent Biotech has a market cap or net worth of $69.14 thousand as of June 17, 2026. Its market cap has decreased by -99.52% in one year.
Market Cap
69.14K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 5, 2014, Nascent Biotech's market cap has decreased from 16.24M to 69.14K, a decrease of -99.57%. That is a compound annual growth rate of -36.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 69.14K | -33.33% |
| Dec 31, 2025 | 103.71K | -98.81% |
| Dec 31, 2024 | 8.74M | -69.97% |
| Dec 29, 2023 | 29.11M | 19.95% |
| Dec 30, 2022 | 24.27M | 341.66% |
| Dec 31, 2021 | 5.49M | 37.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synairgen | 110.27K |
| Sigyn Therapeutics | 99.18K |
| Regen BioPharma | 87.10K |
| Affymax | 74.49K |
| Vincerx Pharma | 68.57K |
| Scorpius Holdings | 67.26K |
| U.S. Stem Cell | 66.15K |
| PaxMedica | 63.14K |